BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36401787)

  • 1. Genetic Alterations of Melanoma Brain Metastases: A Systematic Review and Meta-Analysis.
    Pala L; Bagnardi V; Tettamanzi F; Barberis M; Mazzarol G; Casali C; De Pas T; Pennacchioli E; Coppola S; Baldini F; Cocorocchio E; Ferrucci P; Patane' D; Saponara M; Queirolo P; Conforti F
    Mol Diagn Ther; 2023 Jan; 27(1):5-13. PubMed ID: 36401787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations.
    Marzese DM; Scolyer RA; Roqué M; Vargas-Roig LM; Huynh JL; Wilmott JS; Murali R; Buckland ME; Barkhoudarian G; Thompson JF; Morton DL; Kelly DF; Hoon DS
    Neuro Oncol; 2014 Nov; 16(11):1499-509. PubMed ID: 24968695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas.
    Appenzeller S; Gesierich A; Thiem A; Hufnagel A; Jessen C; Kneitz H; Regensburger M; Schmidt C; Zirkenbach V; Bischler T; Schilling B; Siedel C; Goebeler ME; Houben R; Schrama D; Gehrig A; Rost S; Maurus K; Bargou R; Rosenwald A; Schartl M; Goebeler M; Meierjohann S
    Cancer; 2019 Feb; 125(4):586-600. PubMed ID: 30561760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genomic landscape of breast cancer brain metastases: a systematic review.
    Morgan AJ; Giannoudis A; Palmieri C
    Lancet Oncol; 2021 Jan; 22(1):e7-e17. PubMed ID: 33387511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy number changes of clinically actionable genes in melanoma, non-small cell lung cancer and colorectal cancer-A survey across 822 routine diagnostic cases.
    Pfarr N; Penzel R; Klauschen F; Heim D; Brandt R; Kazdal D; Jesinghaus M; Herpel E; Schirmacher P; Warth A; Weichert W; Endris V; Stenzinger A
    Genes Chromosomes Cancer; 2016 Nov; 55(11):821-33. PubMed ID: 27218826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES).
    Lau PKH; Feran B; Smith L; Lasocki A; Molania R; Smith K; Weppler A; Angel C; Kee D; Bhave P; Lee B; Young RJ; Iravani A; Yeang HA; Vergara IA; Kok D; Drummond K; Neeson PJ; Sheppard KE; Papenfuss T; Solomon BJ; Sandhu S; McArthur GA
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34625515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical exome sequencing as the first-tier test for diagnosing developmental disorders covering both CNV and SNV: a Chinese cohort.
    Dong X; Liu B; Yang L; Wang H; Wu B; Liu R; Chen H; Chen X; Yu S; Chen B; Wang S; Xu X; Zhou W; Lu Y
    J Med Genet; 2020 Aug; 57(8):558-566. PubMed ID: 32005694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous Detection of CNVs and SNVs Improves the Diagnostic Yield of Fetuses with Ultrasound Anomalies and Normal Karyotypes.
    Qi Q; Jiang Y; Zhou X; Meng H; Hao N; Chang J; Bai J; Wang C; Wang M; Guo J; Ouyang Y; Xu Z; Xiao M; Zhang VW; Liu J
    Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33255631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-scale discovery of novel neurodevelopmental disorder-related genes through a unified analysis of single-nucleotide and copy number variants.
    Hamanaka K; Miyake N; Mizuguchi T; Miyatake S; Uchiyama Y; Tsuchida N; Sekiguchi F; Mitsuhashi S; Tsurusaki Y; Nakashima M; Saitsu H; Yamada K; Sakamoto M; Fukuda H; Ohori S; Saida K; Itai T; Azuma Y; Koshimizu E; Fujita A; Erturk B; Hiraki Y; Ch'ng GS; Kato M; Okamoto N; Takata A; Matsumoto N
    Genome Med; 2022 Apr; 14(1):40. PubMed ID: 35468861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolutionary Routes in Metastatic Uveal Melanomas Depend on
    Rodrigues M; Mobuchon L; Houy A; Alsafadi S; Baulande S; Mariani O; Marande B; Ait Rais K; Van der Kooij MK; Kapiteijn E; Gassama S; Gardrat S; Barnhill RL; Servois V; Dendale R; Putterman M; Tick S; Piperno-Neumann S; Cassoux N; Pierron G; Waterfall JJ; Roman-Roman S; Mariani P; Stern MH
    Clin Cancer Res; 2019 Sep; 25(18):5513-5524. PubMed ID: 31227496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular evolutionary process of advanced gastric cancer during sequential chemotherapy detected by circulating tumor DNA.
    Xi W; Zhou C; Xu F; Sun D; Wang S; Chen Y; Ji J; Ma T; Wu J; Shangguan C; Zhu Z; Zhang J
    J Transl Med; 2022 Aug; 20(1):365. PubMed ID: 35962408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of commonly mutated genes in leptomeningeal carcinomatosis.
    Congur I; Koni E; Onat OE; Tokcaer Keskin Z
    PeerJ; 2023; 11():e15250. PubMed ID: 37096065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy number alterations involving 59 ACMG-recommended secondary findings genes.
    Yatsenko SA; Aarabi M; Hu J; Surti U; Ortiz D; Madan-Khetarpal S; Saller DN; Bellissimo D; Rajkovic A
    Clin Genet; 2020 Dec; 98(6):577-588. PubMed ID: 33009833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying Genomic Alterations in Patients With Stage IV Breast Cancer Using MammaSeq: An International Collaborative Study.
    Shah OS; Soran A; Sahin M; Knapick BA; Ugras S; Celik E; Lucas PC; Lee AV
    Clin Breast Cancer; 2021 Jun; 21(3):210-217. PubMed ID: 33191115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concordance of copy number loss and down-regulation of tumor suppressor genes: a pan-cancer study.
    Zhao M; Zhao Z
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):532. PubMed ID: 27556634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes.
    Wang M; Banik I; Shain AH; Yeh I; Bastian BC
    Genome Med; 2022 Jun; 14(1):65. PubMed ID: 35706047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Genome-Wide Analysis of Gene Expression and DNA Copy Number Variations Highlights Stem Cell-Related Pathways in Small Cell Esophageal Carcinoma.
    Liu D; Xu X; Wen J; Xie L; Zhang J; Shen Y; Jiang G; Chen J; Fan M
    Stem Cells Int; 2018; 2018():3481783. PubMed ID: 30228821
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrated Functional Analysis Implicates Syndromic and Rare Copy Number Variation Genes as Prominent Molecular Players in Pathogenesis of Autism Spectrum Disorders.
    Ashitha SNM; Ramachandra NB
    Neuroscience; 2020 Jul; 438():25-40. PubMed ID: 32407977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network-guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma.
    Valsesia A; Rimoldi D; Martinet D; Ibberson M; Benaglio P; Quadroni M; Waridel P; Gaillard M; Pidoux M; Rapin B; Rivolta C; Xenarios I; Simpson AJ; Antonarakis SE; Beckmann JS; Jongeneel CV; Iseli C; Stevenson BJ
    PLoS One; 2011 Apr; 6(4):e18369. PubMed ID: 21494657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.